Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Prolight Diagnostics ABLTS:0G5I 31 Market Cap is kr215.60 Mil as of Aug. 02, 2026. GuruFocus rates LTS:0G5I with a GF Score™ of 31/100. The stock has 1 warning sign investors should review. Among 863 Medical Devices & Instruments companies, Prolight Diagnostics AB ranks worse than 74.74% on this metric.
Prolight Diagnostics AB's quarterly market cap
increased
from Sep. 2025 (kr188.97 Mil) to Dec. 2025 (kr189.11 Mil) but then
stayed the same
from Dec. 2025 (kr189.11 Mil) to Mar. 2026 (kr189.11 Mil).
Prolight Diagnostics AB's annual market cap
declined
from Dec. 2023 (kr1.74 Mil) to Dec. 2024 (kr1.20 Mil) but then
increased
from Dec. 2024 (kr1.20 Mil) to Dec. 2025 (kr189.11 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Prolight Diagnostics AB's Enterprise Value for Today is kr198.34 Mil.
Prolight Diagnostics AB (LTS:0G5I) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Prolight Diagnostics AB Market Cap Related Terms
Prolight Diagnostics AB Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0G5I vs ISRG, BDX, MDLN: Market Cap Comparison
For the Medical Instruments & Supplies subindustry, Prolight Diagnostics AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Prolight Diagnostics AB Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Prolight Diagnostics AB's Market Cap distribution charts can be found below:
* The bar in red indicates where Prolight Diagnostics AB's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Prolight Diagnostics AB's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Prolight Diagnostics AB (LTS:0G5I) has a Market Cap of kr215.60 Mil as of Aug. 02, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Prolight Diagnostics AB and its competitors. According to the industry distribution chart, Prolight Diagnostics AB ranks #645 out of 863 companies in the Medical Devices & Instruments industry, placing it in the top 74.7%.
Is Prolight Diagnostics AB's Market Cap too high?
Prolight Diagnostics AB's current Market Cap is kr215.60 Mil. Based on the distribution chart, Prolight Diagnostics AB ranks #645 out of 863 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Prolight Diagnostics AB has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Prolight Diagnostics AB's Market Cap compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Prolight Diagnostics AB ranks #645 out of 863 companies for Market Cap. This places Prolight Diagnostics AB in the lower half of its industry. The industry median Market Cap is 112.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 112.48, based on 863 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Prolight Diagnostics AB and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 112.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Prolight Diagnostics AB's current Market Cap is kr215.60 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prolight Diagnostics AB stock overvalued right now?
Prolight Diagnostics AB (LTS:0G5I) has a current Market Cap of kr215.60 Mil. The current Market Cap is kr215.60 Mil. Prolight Diagnostics AB's overall GF Score™ is 31/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Prolight Diagnostics AB (LTS:0G5I), the current Market Cap is kr215.60 Mil as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Prolight Diagnostics AB along with its subsidiaries, develops Point-of-Care (POC) systems, which are small, portable instruments and disposable cartridges for performing in-vitro diagnostic (IVD) tests from a drop of blood. Its product portfolio includes Psyros, a digital POC technology, and Microflex.
31GF Score
Get the complete analysis for LTS:0G5I
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0G5I has been successfully added to your 
